Published in Lupus on October 23, 2009
Anti-C1q autoantibodies, novel tests, and clinical consequences. Front Immunol (2013) 0.93
Evaluation of a high avidity anti-dsDNA IgG enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus. Int J Clin Exp Pathol (2011) 0.83
An Overlapping Case of Lupus Nephritis and IgG4-Related Kidney Disease. J Clin Med Res (2015) 0.76
High Avidity dsDNA Autoantibodies in Brazilian Women with Systemic Lupus Erythematosus: Correlation with Active Disease and Renal Dysfunction. J Immunol Res (2015) 0.75
Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis. PLoS One (2016) 0.75
Potential serum and urine biomarkers in patients with lupus nephritis and the unsolved problems. Open Access Rheumatol (2016) 0.75
Anti-DNase I antibodies in systemic lupus erythematosus: diagnostic value and share in the enzyme inhibition. Rheumatol Int (2016) 0.75
The first prospective controlled trial comparing wireless capsule endoscopy with push enteroscopy in chronic gastrointestinal bleeding. Endoscopy (2002) 4.68
Serum levels of cytokines in chronic liver diseases. Gastroenterology (1992) 3.47
Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet (1993) 3.45
Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology (2000) 2.66
Environmental risk factors for REM sleep behavior disorder: a multicenter case-control study. Neurology (2012) 2.54
Incorporation of six additional proteins to complete the assembly map of the 50 S subunit from Escherichia coli ribosomes. J Biol Chem (1987) 2.15
A hitherto unknown infectious disease contracted from monkeys. "Marburg-virus" disease. Ger Med Mon (1968) 1.86
Kleine-Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses. Neurology (2002) 1.85
Correct folding of circularly permuted variants of a beta alpha barrel enzyme in vivo. Science (1989) 1.76
Nucleic acid aptamers-from selection in vitro to applications in vivo. Acc Chem Res (2000) 1.74
Heterologous expression of Arabidopsis phytochrome B in transgenic potato influences photosynthetic performance and tuber development. Plant Physiol (1999) 1.72
DTI reveals hypothalamic and brainstem white matter lesions in patients with idiopathic narcolepsy. Sleep Med (2012) 1.68
Interleukin-1 receptor antagonist in differential diagnosis of inflammatory bowel diseases. Eur J Gastroenterol Hepatol (1995) 1.64
Influence of feeding and sham feeding upon serum gastrin and gastric acid secretion in control subjects and duodenal ulcer patients. Scand J Gastroenterol (1974) 1.63
Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer. J Clin Oncol (1998) 1.61
Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet (1995) 1.59
A randomized, blinded, prospective trial to compare the safety and efficacy of three bowel-cleansing solutions for colonoscopy (HSG-01*). Endoscopy (2003) 1.48
Hypotensive and renin-suppressing activities of propranolol in hypertensive patients. Clin Sci Mol Med Suppl (1975) 1.46
The contribution of adhesion molecule expression in donor kidney biopsies to early allograft dysfunction. Transplantation (2001) 1.45
Prevalence of acquired cystic kidney disease and tumors in native kidneys of renal transplant recipients: a prospective US study. Radiology (1995) 1.41
[Recommendations for diagnosis, therapy and long-term management of patients with sleep apnea]. Med Klin (Munich) (1991) 1.40
Protracted infection of pacemaker leads with development of large vegetations: three years follow up. Case report. Vnitr Lek (2003) 1.39
[Calculated renal function: benefits and problems of the "Modification of Diet in Renal Disease" (MDRD) formula]. Dtsch Med Wochenschr (2005) 1.39
Atrial natriuretic peptide (ANP), aldosterone, angiotensin II and renin in the 'low T3 syndrome' in organ donors. Infusionsther Transfusionsmed (1992) 1.39
[Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?]. Wien Klin Wochenschr (1995) 1.38
Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure. Wien Klin Wochenschr (1998) 1.38
Computed virtual chromoendoscopy versus standard colonoscopy with targeted indigocarmine chromoscopy: a randomised multicentre trial. Gut (2008) 1.34
Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol (2000) 1.32
Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest (1992) 1.28
Acquired c1-inhibitor deficiencies in lymphoproliferative diseases with serum immunoglobulin abnormalities. A study of three cases. Blut (1976) 1.25
Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4. J Immunol (2001) 1.24
Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy. Tissue Antigens (1997) 1.21
Familial renal glucosuria: SLC5A2 mutation analysis and evidence of salt-wasting. Kidney Int (2006) 1.21
The phosphatidyl-myo-inositol anchor of the lipoarabinomannans from Mycobacterium bovis bacillus Calmette Guérin. Heterogeneity, structure, and role in the regulation of cytokine secretion. J Biol Chem (1997) 1.21
Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J Urol (1999) 1.20
Bacillus Calmette-Guérin mycobacteria stimulate human blood dendritic cells. Int J Cancer (1997) 1.19
Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages. Transplantation (1990) 1.18
UROMODULIN mutations cause familial juvenile hyperuricemic nephropathy. J Clin Endocrinol Metab (2003) 1.18
Streptomycin biosynthesis and its regulation in Streptomycetes. Gene (1992) 1.16
HLA and genetic susceptibility to sleepwalking. Mol Psychiatry (2003) 1.15
Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy. Eur J Clin Invest (2009) 1.14
Glomerular permeability barrier in the rat. Functional assessment by in vitro methods. J Clin Invest (1993) 1.14
Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists. Rheumatology (Oxford) (2008) 1.13
Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol (1987) 1.13
EFNS guidelines on management of narcolepsy. Eur J Neurol (2006) 1.13
Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol (1999) 1.12
Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. J Intern Med (2000) 1.11
Gene expression profiles of human proximal tubular epithelial cells in proteinuric nephropathies. Kidney Int (2006) 1.10
Treatment of acquired C1-inhibitor deficiency with danazol. Ann Intern Med (1977) 1.07
Intramers as promising new tools in functional proteomics. Chem Biol (2001) 1.07
Pulmonary sarcoidosis: patterns of cytokine release in vitro. Eur Respir J (1996) 1.07
Aptamers as tools in molecular biology and immunology. Curr Top Microbiol Immunol (1999) 1.06
[On the hitherto unknown, in monkeys originating infectious disease: Marburg virus disease]. Dtsch Med Wochenschr (1968) 1.06
IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses. J Immunol (1988) 1.06
Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination. Am J Kidney Dis (1998) 1.06
IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells. Cytokine (1995) 1.05
The Erlangen Endo-Trainer: life-like simulation for diagnostic and interventional endoscopic retrograde cholangiography. Endoscopy (2000) 1.05
Secondary sclerosing cholangitis after long-term treatment in an intensive care unit: clinical presentation, endoscopic findings, treatment, and follow-up. Endoscopy (2006) 1.04
Neopterin in clinical practice. Clin Chim Acta (1991) 1.04
Chronomics, neuroendocrine feedsidewards and the recording and consulting of nowcasts--forecasts of geomagnetics. Biomed Pharmacother (2005) 1.03
Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review. Diabet Med (2012) 1.03
Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parameters. Ann Hematol (1991) 1.02
Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group. Ann Oncol (2004) 1.01
In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS). Clin Exp Immunol (1988) 0.99
Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy. Am J Kidney Dis (2001) 0.99
Four consecutive renal transplantations in a patient with adenine phosphoribosyltransferase deficiency. Clin Nephrol (2004) 0.98
Efficacy and safety of a combined rituximab chemotherapy during pregnancy. J Clin Oncol (2001) 0.98
Evaluation of cytokines and cytokine-induced secondary messages in sera of patients after liver transplantation. Transplantation (1990) 0.98
Augmentation of albumin but not fibrinogen synthesis by corticosteroids in patients with hepatocellular disease. J Clin Invest (1970) 0.98
Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study. Pharmacopsychiatry (2002) 0.98
Olfactory dysfunction in patients with narcolepsy with and without REM sleep behaviour disorder. Brain (2007) 0.97
Altered circadian rhythms of the stress hormone and melatonin response in lupus-prone MRL/MP-fas(Ipr) mice. J Autoimmun (2000) 0.96
[Influence of reflex zone therapy of the feet on intestinal blood flow measured by color Doppler sonography]. Forsch Komplementarmed Klass Naturheilkd (2001) 0.95
Plasma immunadsorption treatment in patients with primary focal and segmental glomerulosclerosis. Nephrol Dial Transplant (1998) 0.95
Consequences of 6 weeks of strength training on red cell O2 transport and iron status. Eur J Appl Physiol Occup Physiol (1990) 0.94
Different effects of interferons, interleukin-1beta and tumor necrosis factor-alpha in normal (OSE) and malignant human ovarian epithelial cells. Int J Cancer (1996) 0.94
Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm (Vienna) (2005) 0.94
Modulatory potential of iron chelation therapy on nitric oxide formation in cerebral malaria. J Infect Dis (1997) 0.94
Immune response modulation by pentoxifylline in vitro. Transplantation (1993) 0.94
Manual and verbal responses to completely masked (unreportable) stimuli: exploring some conditions for the metacontrast dissociation. Perception (1998) 0.93
Anticoagulant characteristics of HD1-22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase. J Thromb Haemost (2008) 0.93
The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: a prospective follow-up. J Am Soc Nephrol (1999) 0.93
Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma. J Clin Oncol (1989) 0.93
Atubular glomeruli in patients with chronic allograft rejection. Transplantation (1996) 0.92
Protein biomarkers associated with acute renal failure and chronic kidney disease. Eur J Clin Invest (2006) 0.92
Velocity of propagation in vertebrate cardiac muscles as functions of tonicity and [K+]. Am J Physiol (1970) 0.92
Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma. Cochrane Database Syst Rev (2007) 0.92
The effects of blood pressure reduction on cyclosporine nephrotoxicity in the rat. J Am Soc Nephrol (1993) 0.92
Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease. Hepatology (1993) 0.92
Immunoglobulin E and immunoglobulin G subclass distribution in vivo and relationship to in vitro generation of interferon-gamma and neopterin in patients with severe atopic dermatitis. Int Arch Allergy Appl Immunol (1988) 0.91
Seasonality in communication and collective decision-making in ants. Proc Biol Sci (2014) 0.91
Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer. Int J Cancer (1996) 0.91
Multiple-dose pharmacokinetics of cefpirome in long-term hemodialysis with high-flux membranes. Clin Pharmacol Ther (1996) 0.91
Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma). Clin Exp Immunol (1991) 0.90
Associations between cellular immune effector function, iron metabolism, and disease activity in patients with chronic hepatitis C virus infection. J Infect Dis (1999) 0.90